Translational regulation of NeuroD1 expression by FMRP: Involvement in glutamatergic neuronal differentiation of cultured rat primary neural progenitor cells

Cellular and Molecular Neurobiology

Volumn 34, Issue 2, 2014, Pages 297-305

  Jeon, Se Jin ^a   Kim, Ji Woon ^a   Kim, Ki Chan ^a   Han, So Min ^a   Go, Hyo Sang ^a   Seo, Jung Eun ^a   Choi, Chang Soon ^a   Ryu, Jong Hoon ^b   Shin, Chan Young ^a   Song, Mi Ryoung ^c  

^a Konkuk University School of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

^c Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

FMRP; Neural progenitor cell; NeuroD1; Neuronal differentiation

Indexed keywords

ANISOMYCIN; CYCLOHEXIMIDE; FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; NEUROGENIC DIFFERENTIATION FACTOR; NEUROGENIN 2; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSOLIC FRACTION; DOWN REGULATION; FEMALE; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROMODULATION; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLUTAMATES; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; NEURONS; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SYNAPSES; VALPROIC ACID;

EID: 84903367135     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-0014-9     Document Type: Article

References (47)

1. Adusei DC, Pacey LK, Chen D, Hampson DR (2010) Early developmental alterations in GABAergic protein expression in fragile X knockout mice. Neuropharmacology 59(3):167-171. doi:10.1016/j.neuropharm.2010.05.002
2. Bassell GJ, Warren ST (2008) Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60(2):201-214. doi:10.1016/j.neuron.2008.10.004
3. Brill MS, Ninkovic J, Winpenny E, Hodge RD, Ozen I, Yang R, Lepier A, Gascon S, Erdelyi F, Szabo G, Parras C, Guillemot F, Frotscher M, Berninger B, Hevner RF, Raineteau O, Gotz M (2009) Adult generation of glutamatergic olfactory bulb interneurons. Nat Neurosci 12(12):1524-1533. doi:10.1038/nn.2416
4. Brown V, Small K, Lakkis L, Feng Y, Gunter C, Wilkinson KD, Warren ST (1998) Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J Biol Chem 273(25):15521-15527 (Pubitemid 28298162)
5. Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, Darnell RB, Warren ST (2001) Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107(4):477-487 (Pubitemid 33152783)
6. Castren M, Tervonen T, Karkkainen V, Heinonen S, Castren E, Larsson K, Bakker CE, Oostra BA, Akerman K (2005) Altered differentiation of neural stem cells in fragile X syndrome. Proc Natl Acad Sci USA 102(49):17834-17839. doi:10.1073/pnas.0508995102 (Pubitemid 41803583)
7. Chiurazzi P, Pomponi MG, Pietrobono R, Bakker CE, Neri G, Oostra BA (1999) Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum Mol Genet 8(12):2317-2323 (Pubitemid 29525348)
8. Curia G, Papouin T, Seguela P, Avoli M (2009) Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. Cereb Cortex 19(7):1515-1520. doi:10.1093/cercor/bhn159
9. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, Licatalosi DD, Richter JD, Darnell RB (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146(2):247-261. doi:10.1016/j.cell.2011.06.013
10. D'Hulst C, De Geest N, Reeve SP, Van Dam D, De Deyn PP, Hassan BA, Kooy RF (2006) Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res 1121(1):238-245. doi:10.1016/j.brainres.2006.08.115 (Pubitemid 44708899)
11. Eberhart DE, Malter HE, Feng Y, Warren ST (1996) The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 5(8):1083-1091 (Pubitemid 26318545)
12. El Idrissi A, Ding XH, Scalia J, Trenkner E, Brown WT, Dobkin C (2005) Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse. Neurosci Lett 377(3):141-146. doi:10.1016/j.neulet.2004.11.087 (Pubitemid 40332346)
13. Englund C, Fink A, Lau C, Pham D, Daza RA, Bulfone A, Kowalczyk T, Hevner RF (2005) Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex. J Neurosci 25(1):247-251. doi:10.1523/JNEUROSCI.2899-04.2005 (Pubitemid 40110787)
14. Fatemi SH, Folsom TD (2011) Dysregulation of fragile X mental retardation protein and metabotropic glutamate receptor 5 in superior frontal cortex of individuals with autism: a postmortem brain study. Mol Autism 2:6. doi:10.1186/2040-2392-2-6
15. Fatemi SH, Folsom TD, Kneeland RE, Liesch SB (2011) Metabotropic glutamate receptor 5 upregulation in children with autism is associated with under expression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism. Anat Rec (Hoboken) 294(10):1635-1645. doi:10.1002/ar.21299
16. Fatemi SH, Folsom TD, Kneeland RE, Yousefi MK, Liesch SB, Thuras PD (2013) Impairment of fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling and its downstream cognates ras-related C3 botulinum toxin substrate 1, amyloid beta A4 precursor protein, striatal-enriched protein tyrosine phosphatase, and homer 1, in autism: a postmortem study in cerebellar vermis and superior frontal cortex. Mol Autism 4(1):21. doi:10.1186/2040-2392-4- 21
17. Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM (1997) Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17(5):1539-1547 (Pubitemid 27089800)
18. Gantois I, Vandesompele J, Speleman F, Reyniers E, D'Hooge R, Severijnen LA, Willemsen R, Tassone F, Kooy RF (2006) Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol Dis 21(2):346-357. doi:10.1016/j.nbd.2005.07.017 (Pubitemid 43099858)
19. Gatto CL, Broadie K (2010) Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci 2:4. doi:10.3389/fnsyn.2010.00004
20. Go HS, Shin CY, Lee SH, Jeon SJ, Kim KC, Choi CS, Ko KH (2009) Increased proliferation and gliogenesis of cultured rat neural progenitor cells by lipopolysaccharide-stimulated astrocytes. NeuroImmunoModulation 16(6):365-376. doi:10.1159/000228911
21. Hagerman R, Lauterborn J, Au J, Berry-Kravis E (2012) Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ 54:297-335. doi:10.1007/978-3-642-21649-7-17
22. Hevner RF, Hodge RD, Daza RA, Englund C (2006) Transcription factors in glutamatergic neurogenesis: conserved programs in neocortex, cerebellum, and adult hippocampus. Neurosci Res 55(3):223-233. doi:10.1016/j.neures.2006.03.004 (Pubitemid 43766416)
23. Hoeffer CA, Sanchez E, Hagerman RJ, Mu Y, Nguyen DV, Wong H, Whelan AM, Zukin RS, Klann E, Tassone F (2012) Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav 11(3):332-341. doi:10.1111/j.1601-183X.2012.00768.x
24. Hou L, Antion MD, Hu D, Spencer CM, Paylor R, Klann E (2006) Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51(4):441-454. doi:10.1016/j.neuron.2006.07.005 (Pubitemid 44189802)
25. Hsieh J, Eisch AJ (2010) Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind. Neurobiol Dis 39(1):73-84. doi:10.1016/j.nbd.2010.01.008
26. Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH (2004) Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 101(47):16659-16664. doi:10.1073/pnas.0407643101 (Pubitemid 39557769)
27. Jeon SJ, Bak H, Seo J, Han SM, Lee SH, Han S-H, Kwon KJ, Ryu JH, Cheong JH, Ko KH, Yang S-I, Choi JW, Park SH, Shin CY (2012a) Oroxylin A Induces BDNF Expression on Cortical Neurons through Adenosine A2A Receptor Stimulation: a Possible Role in Neuroprotection. Biomol Ther 20(1):9
28. Jeon SJ, Han SH, Yang SI, Choi JW, Kwon KJ, Park SH, Kim HY, Cheong JH, Ryu JH, Ko KH, Wells DG, Shin CY (2012b) Positive feedback regulation of Akt-FMRP pathway protects neurons from cell death. J Neurochem 123(2):226-238. doi:10.1111/j.1471-4159.2012.07886.x
29. Kim KC, Kim P, Go HS, Choi CS, Yang SI, Cheong JH, Shin CY, Ko KH (2011) The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol Lett 201(2):137-142. doi:10.1016/j.toxlet.2010.12. 018
30. Kim KC, Kim P, Go HS, Choi CS, Park JH, Kim HJ, Jeon SJ, Dela Pena IC, Han SH, Cheong JH, Ryu JH, Shin CY (2013a) Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder. J Neurochem 124(6):832-843. doi:10.1111/jnc.12147
31. Kim KC, Lee D-K, Go HS, Kim P, Choi CS, Kim J-W, Jeon SJ, Song M-R, Shin CY (2013b) Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring. Mol Neurobiol. doi:10.1007/s12035-013-8535-2
32. Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B, Bach I, Heinzel T, Gottlicher M (2003) The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 22(13):3411-3420. doi:10.1093/emboj/cdg315 (Pubitemid 36834871)
33. Levenga J, Hayashi S, de Vrij FM, Koekkoek SK, van der Linde HC, Nieuwenhuizen I, Song C, Buijsen RA, Pop AS, Gomezmancilla B, Nelson DL, Willemsen R, Gasparini F, Oostra BA (2011) AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome. Neurobiol Dis 42(3):311-317. doi:10.1016/j.nbd.2011.01.022
34. Lohith TG, Osterweil EK, Fujita M, Jenko KJ, Bear MF, Innis RB (2013) Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome? Mol Autism 4(1):15. doi:10.1186/2040-2392-4-15
35. Miyashiro KY, Beckel-Mitchener A, Purk TP, Becker KG, Barret T, Liu L, Carbonetto S, Weiler IJ, Greenough WT, Eberwine J (2003) RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37(3):417-431 (Pubitemid 36183364)
36. Nalavadi VC, Muddashetty RS, Gross C, Bassell GJ (2012) Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation. J Neurosci 32(8):2582-2587
37. Nishimura Y, Martin CL, Vazquez-Lopez A, Spence SJ, Alvarez-Retuerto AI, Sigman M, Steindler C, Pellegrini S, Schanen NC, Warren ST, Geschwind DH (2007) Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet 16(14):1682-1698. doi:10.1093/hmg/ddm116
38. Olmos-Serrano JL, Paluszkiewicz SM, Martin BS, Kaufmann WE, Corbin JG, Huntsman MM (2010) Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J Neurosci 30(29):9929-9938. doi:10.1523/JNEUROSCI.1714-10.2010
39. Rinaldi T, Kulangara K, Antoniello K, Markram H (2007) Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci USA 104(33):13501-13506. doi:10.1073/pnas.0704391104 (Pubitemid 47293974)
40. Saffary R, Xie Z (2011) FMRP regulates the transition from radial glial cells to intermediate progenitor cells during neocortical development. J Neurosci 31(4):1427-1439. doi:10.1523/JNEUROSCI.4854-10.2011
41. Schaeffer C, Bardoni B, Mandel JL, Ehresmann B, Ehresmann C, Moine H (2001) The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J 20(17):4803-4813. doi:10.1093/emboj/20.17. 4803 (Pubitemid 32848632)
42. Sgado P, Genovesi S, Kalinovsky A, Zunino G, Macchi F, Allegra M, Murenu E, Provenzano G, Tripathi PP, Casarosa S, Joyner AL, Bozzi Y (2013) Loss of GABAergic neurons in the hippocampus and cerebral cortex of Engrailed-2 null mutant mice: implications for autism spectrum disorders. Exp Neurol 247:496-505. doi:10.1016/j.expneurol.2013.01.021
43. Sharma A, Hoeffer CA, Takayasu Y, Miyawaki T, McBride SM, Klann E, Zukin RS (2010) Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30(2):694-702
44. Tabolacci E, De Pascalis I, Accadia M, Terracciano A, Moscato U, Chiurazzi P, Neri G (2008) Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation. Pharmacogenet Genomics 18(8):738-741
45. Tervonen TA, Louhivuori V, Sun X, Hokkanen ME, Kratochwil CF, Zebryk P, Castren E, Castren ML (2009) Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome. Neurobiol Dis 33(2):250-259. doi:10.1016/j.nbd.2008.10.010
46. Winpenny E, Lebel-Potter M, Fernandez ME, Brill MS, Gotz M, Guillemot F, Raineteau O (2011) Sequential generation of olfactory bulb glutamatergic neurons by Neurog2-expressing precursor cells. Neural Dev 6:12. doi:10.1186/1749-8104- 6-12
47. Yu IT, Park JY, Kim SH, Lee JS, Kim YS, Son H (2009) Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 56(2):473-480. doi:10.1016/j.neuropharm.2008.09.019